Ex Vivo Priming of Endothelial Progenitor Cells With SDF-1 Before Transplantation Could Increase Their Proangiogenic Potential

Objectives—As SDF-1 and its cognate receptor CXCR4 play a key role in the survival and mobilization of immature cells, we examined whether preconditioning of endothelial progenitor cells (EPCs) with SDF-1 could further promote their capacity to enhance angiogenesis. Methods and Results—EPC exposure to 100 ng/mL SDF-1 for 30 min induced a proangiogenic phenotype, with cell migration and differentiation into vascular cords in Matrigel and increased their therapeutic potential in a nude mouse model of hindlimb ischemia. This pretreatment enhanced EPC adhesion to activated endothelium in physiological conditions of blood flow by stimulating integrin-mediated EPCs binding to endothelial cells. Pretreated EPCs showed significantly upregulated surface α4 and αM integrin subunit expression involved in the homing of immature cells to a neovasculature and enhanced FGF-2 and promatrix metalloproteinase (MMP)-2 secretion. All these effects were significantly attenuated by EPC incubation with AMD-3100, a CXCR4 antagonist, by prior HSPGs disruption and by HUVEC incubation with anti–intercellular adhesion molecule1 (ICAM-1) and anti–vascular cell adhesion molecule (VCAM) blocking antibodies. Pretreated EPCs adhered very rapidly (within minutes) and were resistant to shear stresses of up to 2500s−1. Conclusions—SDF-1 pretreatment during EPC expansion stimulates EPC adhesion to endothelial cells and thus augments the efficiency of cell therapy for ischemic vascular diseases.

[1]  P. Huijgens,et al.  Proteoglycans on bone marrow endothelial cells bind and present SDF-1 towards hematopoietic progenitor cells , 2003, Leukemia.

[2]  A. Schecter,et al.  epidermal growth factor receptor , 2005 .

[3]  T. Springer,et al.  The integrin VLA-4 supports tethering and rolling in flow on VCAM-1 , 1995, The Journal of cell biology.

[4]  M. Sands,et al.  VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. Alon,et al.  The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. , 2000, Blood.

[6]  I. Bièche,et al.  Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy. , 2001, Cancer research.

[7]  C. Jiao,et al.  Differential Healing Activities of CD34+ and CD14+ Endothelial Cell Progenitors , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[8]  Fan Zhang,et al.  Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes , 2006, Nature Medicine.

[9]  Luke P. Lee,et al.  Role of cell surface heparan sulfate proteoglycans in endothelial cell migration and mechanotransduction , 2005, Journal of cellular physiology.

[10]  M. Springer.  A balancing act: therapeutic approaches for the modulation of angiogenesis. , 2006, Current opinion in investigational drugs.

[11]  R. Alon,et al.  The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. , 2000, Blood.

[12]  B. Engelhardt,et al.  Multistep Nature of Microvascular Recruitment of Ex Vivo–expanded Embryonic Endothelial Progenitor Cells during Tumor Angiogenesis , 2003, The Journal of experimental medicine.

[13]  B. Lévy,et al.  PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells. , 2007, The Journal of clinical investigation.

[14]  J. Mary,et al.  Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. , 1998, Blood.

[15]  J. Chun,et al.  Sphingosine-1-Phosphate Stimulates the Functional Capacity of Progenitor Cells by Activation of the CXCR4-Dependent Signaling Pathway via the S1P3 Receptor , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[16]  M. Sata,et al.  CXCR4, a key modulator of vascular progenitor cells. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[17]  Younghee Lee,et al.  Overexpression of stromal cell-derived factor-1 enhances endothelium-supported transmigration, maintenance, and proliferation of hematopoietic progenitor cells. , 2006, Stem cells and development.

[18]  L. Muller,et al.  PAR-1 Activation on Human Late Endothelial Progenitor Cells Enhances Angiogenesis In Vitro With Upregulation of the SDF-1/CXCR4 System , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[19]  A. Zeiher,et al.  Cell-enhancement strategies for the treatment of ischemic heart disease , 2007, Nature Clinical Practice Cardiovascular Medicine.

[20]  T. Asahara,et al.  Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[21]  Geoffrey C Gurtner,et al.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 , 2004, Nature Medicine.

[22]  R. Alon,et al.  The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow. , 1999, The Journal of clinical investigation.

[23]  J. Isner,et al.  Stromal Cell–Derived Factor-1 Effects on Ex Vivo Expanded Endothelial Progenitor Cell Recruitment for Ischemic Neovascularization , 2003, Circulation.

[24]  D. Benisvy,et al.  Low-molecular-weight fucoidan enhances the proangiogenic phenotype of endothelial progenitor cells. , 2005, Biochemical pharmacology.

[25]  P. Boekstegers,et al.  Embryonic endothelial progenitor cells expressing a broad range of proangiogenic and remodeling factors enhance vascularization and tissue recovery in acute and chronic ischemia , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  D. Stupack,et al.  A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. , 2006, The Journal of clinical investigation.

[27]  G. Godeau,et al.  Fucoidan a sulfated polysaccharide from brown algae is a potent modulator of connective tissue proteolysis. , 2006, Archives of biochemistry and biophysics.

[28]  M. Isobe,et al.  Endothelial E-Selectin Potentiates Neovascularization via Endothelial Progenitor Cell–Dependent and –Independent Mechanisms , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[29]  Y. Shiba,et al.  M-CSF Accelerates Neointimal Formation in the Early Phase After Vascular Injury in Mice: The Critical Role of the SDF-1–CXCR4 System , 2006, Arteriosclerosis, thrombosis, and vascular biology.